In line with all these studies, our results also demonstrated that there was a significantly higher rate of E-cadherin loss and higher expressions of N-cadherin, Snail, Twist, Vimentin and Zeb1 in invasive carcinoma in comparison to DCIS. The gene discussed is CDH2; the disease is ductal breast carcinoma in situ.